SCHEMBL6833306

SCHEMBL6833306

CONS(=O)(=O)c1ccc(Cl)s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.54
KMT2A Q03164 6/20 0.53
ALDH1A1 P00352 4/20 0.53
HTT P42858 2/20 0.53
GAA P10253 1/20 0.53
HPGD P15428 1/20 0.53
CCR5 P51681 2/20 0.52
MEN1 O00255 3/20 0.51
PABPC1 P11940 1/20 0.51
MAPT P10636 3/20 0.50
TDP1 Q9NUW8 1/20 0.50
TSHR P16473 1/20 0.50
CCR4 P51679 1/20 0.48
PSEN1 P49768 2/20 0.47
PSEN2 P49810 2/20 0.47
APH1B Q8WW43 2/20 0.47
NCSTN Q92542 2/20 0.47
APH1A Q96BI3 2/20 0.47
PSENEN Q9NZ42 2/20 0.47
PTGES2 Q9H7Z7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12228299 0.79 KMT2A (0.54) SMN1; SMN2KMT2AALDH1A1HTTGAA
SCHEMBL24254279 0.78 KMT2A (0.56) SMN1; SMN2KMT2AALDH1A1HTTGAA
SCHEMBL5509510 0.78 LMNA (0.56) SMN1; SMN2KMT2AALDH1A1HTTHPGD
SCHEMBL1925504 0.76 MAPT (0.48) SMN1; SMN2KMT2AALDH1A1HTTGAA
SCHEMBL1925554 0.76 MAPT (0.48) SMN1; SMN2KMT2AALDH1A1HTTGAA
SCHEMBL8198000 0.75 SMN1; SMN2 (0.46) SMN1; SMN2KMT2AALDH1A1HTTGAA
SCHEMBL4207122 0.75 KMT2A (0.53) SMN1; SMN2KMT2AALDH1A1HTTGAA
SCHEMBL8230214 0.75 KMT2A (0.53) SMN1; SMN2KMT2AALDH1A1HTTGAA
SCHEMBL1523222 0.74 ALDH1A1 (0.54) SMN1; SMN2KMT2AALDH1A1HTTGAA
SCHEMBL16012975 0.74 KMT2A (0.67) SMN1; SMN2KMT2AALDH1A1HTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040023938-A1 Sulfonamide derivatives TABUCHI TAKANORI (JP) 2004-02-05 US disclosed
US-6586617-B1 Nontoxic microbiocides such as 4'-chloro-N-ethyl-2'-nitro-p-toluenesulfonanilide, for agricultural or horticultural, prepared by alkylation or nitration SUMITOMO CHEMICAL TAKEDA AGRO COMPANY, LIMITED (JP) 2003-07-01 US disclosed
EP-1174028-A1 SULFONAMIDE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2002-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040023938-A1 Sulfonamide derivatives FPR1, MRM1, SULT1E1 SMN1; SMN2 1033/4885KMT2A 563/4885ALDH1A1 453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.